Sterimedix Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sterimedix Limited - overview
Established
1989
Location
London, England, UK
Primary Industry
Medical Devices & Equipment
About
Sterimedix Limited manufactures single-use ophthalmic medical devices aimed at enhancing surgical outcomes in eye care, offering precision-engineered products for various ocular procedures. Founded in 1989, Sterimedix specializes in the production of ophthalmic medical devices, particularly focusing on single-use products. The company operates from its headquarters in the United Kingdom and has expanded its market reach to over 60 countries, including key markets in Europe, North America, and Asia. While there are no known pivots or shifts in business strategy, Sterimedix has maintained its commitment to quality and precision in eye care.
The founder's background and previous ventures are not publicly available. Sterimedix specializes in the manufacturing of single-use ophthalmic medical devices, focusing on precision-engineered products that enhance surgical outcomes in eye care. The company’s core offerings include ophthalmic cannulas, Irrigation Aspiration Handpieces, and aesthetic cannulas, which assist surgeons in various eye procedures, such as cataract surgery and ocular interventions. These products meet stringent safety and efficacy standards required in the medical field, providing reliable tools that help restore or protect patients’ vision.
Sterimedix caters to a global clientele, serving healthcare providers, hospitals, and surgical centers across more than 60 countries, including key markets in Europe, North America, and Asia. Sterimedix operates on a business-to-business model, generating revenue primarily through direct sales to healthcare institutions and distributors within the ophthalmic sector. The pricing structure reflects the high-quality standards of their products, with clients placing bulk orders for devices like ophthalmic cannulas and handpieces to ensure a consistent supply for surgical procedures. This approach facilitates streamlined inventory management for healthcare providers and strengthens relationships with distributors and healthcare professionals who rely on Sterimedix products for effective patient care.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Medical Supplies
Website
www.sterimedix.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Sterimedix Limited - timeline of key events

Sterimedix Limited - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue (USD) | 9,539,235 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | 3,525,690 | - | - | - |
| Operating Income (USD) | 3,356,489 | - | - | - |
| Operating Margin | 35.2% | - | - | - |
| % EBITDA Margin | 37.0% | - | - | - |
| NET Income (USD) | 2,713,043 | - | - | - |
| % Net Margin | 28.4% | - | - | - |
Sterimedix Limited - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.